| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.073 | 0.6 |